The comparative effectiveness of antidepressants for youths with major depressive disorder: a nationwide population-based study in Taiwan.
Sheng-Yu LeeLiang-Jen WangYao-Hsu YangChih-Wei HsuPublished in: Therapeutic advances in chronic disease (2022)
We concluded that bupropion might surpass fluoxetine with regard to hospitalisation prevention and drug therapy maintenance among youths with MDD, while mirtazapine users demonstrated a higher hospitalisation risk. Our findings might serve as a reference for clinicians in future studies.